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Abstract This study aimed to estimate the prevalence of
musculoskeletal disorders and rheumatic diseases among the
indigenous Qom (Toba) population in the city of Rosario,
Santa Fe, Argentina. An analytical cross-sectional study using
methodology of the Community Oriented Program for the
Control of Rheumatic Diseases (COPCORD) was performed.
Subjects ≥18 years of age were interviewed by advanced stu-
dents of medicine and nursing, bilingual translator-facilitators,
and coordinators. Individuals with musculoskeletal pain (pos-
itive cases) were evaluated sequentially for 7 days by inter-
nists and rheumatologists for diagnosis and treatment. The
study included 1656 individuals (77 % of the census popula-
tion). Of these, 1020 (61.5 %) were female, with mean age of
35.3 (SD 13.9) years, and 1028 (62.0 %) were bilingual. The
public health care system covers 87.1 % of the population.
Musculoskeletal pain in the previous 7 days and/or at some
time during their life was present in 890 subjects (53.7 %). Of
those with pain in the last 7 days, 302 (64.1 %) subjects had an
Health Assessment Questionnaire Disability Index (HAQ-DI)
score ≥0.8. The most frequent pain sites were lumbar spine
(19.3 %), knees (13.0 %), and hands (12.0 %). The prevalence
of rheumatic diseases was as follows: mechanical back pain
(20.1 %), rheumatic regional pain syndrome (2.9 %), osteoar-
thritis (4.0%) rheumatoid arthritis (2.4%), inflammatory back
pain (0.2 %), systemic sclerosis (0.1 %), Sjögren syndrome
(0.1 %), fibromyalgia (0.1 %), mixed connective tissue dis-
ease (0.06 %), and systemic lupus erythematosus (0.06 %).
The prevalence of musculoskeletal disorders was 53.7 % and
rheumatic diseases 29.6 %. Rheumatoid arthritis prevalence
was 2.4 % using COPCORD methodology, one of the highest
reported at present.
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Introduction
Rheumatic diseases represent a broad and heterogeneous
group of pathologies related to frequent disabilities and im-
paired quality of life, some associated with increased mortal-
ity. In 2000, the World Health Organization (WHO) raised the
priority for musculoskeletal (MSK) disorders as a major
health issue owing to secondary disability, and through an
increased use of health resources, officially launched what is
known as the Bone and Joint Decade (2000–2010) [1].
TheWHO and the International League of Associations for
Rheumatology (ILAR) developed the Community Oriented
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Program for the Control of Rheumatic Diseases (COPCORD)
for the purpose of obtaining data on MSK disorders and rheu-
matic diseases in developing countries, in a simple and eco-
nomical way. The COPCORD methodology has been used in
several Asian and Middle Eastern countries, as well as in
Australia [2–5]. Additionally, several countries in Latin
America, such as México [6], Guatemala [7], Cuba [8], Peru
[9], Venezuela [10], and Brazil [11], have also implemented
this methodology.
It is estimated that 400 different indigenous groups live
throughout Latin America. The countries with the highest
proportion of indigenous populations are Bolivia,
Guatemala, and Peru, following by Belize, Mexico, and
Honduras [12]. Owing to Latin America’s characteristic eth-
nicity and sociodemographic profile (a mostly mestizo popu-
lation with low socioeconomic status) and considering that
people of indigenous ancestry often show a worse prognosis
of some diseases, such as systemic lupus erythematosus (SLE)
and rheumatoid arthritis (RA), two multinational and multi-
center study groups were created, the Latin American Group
for the Study of Lupus (Grupo Latino Americano De Estudio
del Lupus; GLADEL) and the Latin American Group for the
Study of Rheumatoid Arthritis (Grupo Latino Americano de
estudio De Artritis Reumatoide; GLADAR). These groups
have reported significant differences especially in terms of
age at disease onset, delay in diagnosis, clinical features, and
disease activity and severity [13–16].
Because of a need for reliable data regarding MSK disor-
ders and rheumatic diseases in the Latin American indigenous
population, the Latin American Group for the Study of
Rheumatic Diseases in Original Populations was created
(Grupo Latino Americano De estudio de Enfermedades
Reumáticas en Pueblos Originarios; GLADERPO). The main
purpose in the first phase was to carry out epidemiological,
anthropological, and genetic studies, so as to trigger interven-
tion processes in the affected populations during the second
phase. Currently, studies in several indigenous populations
from Argentina, Mexico, and Venezuela are being conducted.
There are several groups of indigenous people in
Argentina. According to the latest census in 2010, it is esti-
mated that nearly 1,000,000 inhabitants identified themselves
as belonging to or descendants of an indigenous ethnic group
[17]. The Qom or Toba people belong to the ethnic group
known as Guaycurú. They originally lived in northern
Argentina and expanded to the neighboring countries of
Bolivia and Paraguay, called the BGran Chaco^ region. With
the arrival of Europeans and subsequent land-grabbing and
deforestation, native people were forced to leave their natural
environment and relocate to various areas throughout
Argentina, among these, the city of Rosario. Owing to its so-
cial inclusion policies and relative geographical proximity to
Qom native homelands, Rosario has become one of the most
densely populated nuclei apart from their places of origin [18].
The aim of this study is to estimate the prevalence of MSK
disorders and rheumatic diseases among the Qom population
living in Rosario, Santa Fe Province, Argentina.
Materials and methods
A community-based epidemiological, analytical cross-
sectional study was carried out using the methodology of
COPCORD in the Qom population living in Rosario,
Argentina.
Study population
We included individuals ≥18 years of age who self-identified
as Qom and had been resident for at least 6 months in Rosario.
Rosario is a city located 306 km north of the capital of
Argentina, with a population of more than 1,190,000 [17].
The Qom population is located in the following three districts:
Northern (borough of Travesía), Northwest (borough of
Pumitas), and Western (borough of Rouillón). There were
no official data available on the number of individuals
residing in the city, owing to high migration. Therefore,
it was necessary to conduct a population census and map
the collected data.
Survey
The COPCORD questionnaire, which has been previously
transculturally adapted and validated, served as the data col-
lection tool [19]. The questionnaire was administered by ad-
vanced students of medicine and nursing who had been
trained. These students were accompanied by bilingual
Spanish/Qom translators-facilitators and coordinators. The
COPCORD questionnaire consists of the following four sec-
tions: an explanatory section; a section that includes
sociodemographic data, work history, and self-reported ill-
nesses; and a section to identify MSK pain in the last 7 days
or at some time during the subject’s lifetime, which queries
features such as pain intensity, physical limitation, adaptation,
and help-seeking behavior and medical and/or traditional
treatment. Finally, the questionnaire includes a section de-
signed to assess functional capacity, measured by the short
and validated Health Assessment Questionnaire Disability
Index (HAQ-DI) [20].
In addition, a survey using socioeconomic and health indi-
cators was specifically designed by primary health care teams.
The survey included time of residence in the neighborhood,
degree of formal education, health coverage, monthly income,
and living conditions.
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Study design
At baseline, the strategy included a pilot study with 103 Qom
individuals from the borough of Pumitas; these subjects were
excluded from the extended epidemiological study [19].
Implementation of the survey was done through door-to-
door home visits in the three districts. If the individual was not
at home, visits were repeated at different times and days of the
week, for at least five times; after this, the participant was
considered Babsent.^
Home visits began with a presentation given by the Qom
facilitator, who explained the purpose of the study, participant
confidentiality, and the future use of the data. People were
invited to participate and an informed consent form was pro-
vided, with enough time given for individuals to read and
understand it. If the individual was illiterate, the consent pro-
cedure was verbally explained. Signing of informed consent
was done in front of witnesses, a translator/facilitator, and a
representative of the Provincial Ministry of Health.
All subjects reporting pain, swelling, or stiffness over the
last 7 days or at any point during their lifetime were consid-
ered positive for clinical examination by an internal medicine
specialist. If any examined subject had a clinical evaluation
suggesting a rheumatic disease, they were referred to a rheu-
matologist within the next 7 days for diagnosis and treatment.
The study lasted a total of 18 months.
A rheumatologist provided the diagnosis according to stan-
dardized criteria for RA [21], SLE [22], systemic sclerosis
(SSc) [23], Sjögren syndrome (SS) [24], mixed connective
tissue disease (MCTD) [25], inflammatory back pain [26],
osteoarthritis (OA) [27], back pain [28], fibromyalgia [29],
and rheumatic regional pain syndrome (RRPS) [30]. In the
case of back pain or probable RRPS, validated questionnaires
were administered [6, 30, 31]. These disorders, which could
not be included in the previously named categories, were des-
ignated unknown MSK disorders (UMSK), according to the
International Classification of Diseases, 10th Revision (ICD-
10), published by the WHO [32].
Ethical aspects
The study was approved on December 22, 2010 by the
Research Ethics Committee of the Health Department of the
Municipality of Rosario (Resolution No. 1659/2009), with the
support of the Ministry of Health (resolutions 1619/2010 and
0127/2011) and the Ministry of Social Development of the
Province of Santa Fe, the Association of Rheumatology of
Santa Fe, Faculty of Medical Sciences, National University
of Rosario, and representatives of Qom city organizations.
The study was registered (registration order number 13) with
the Provincial Bioethics Committee of the Province of Santa
Fe on July 5, 2012.
Statistical analysis
The data were entered via a web interface into a database
designed for the study. All analyses were conducted using
Stata v.11.0 (StataCorp, College Station, TX, USA). A de-
scriptive analysis with measures of central tendency and dis-
persion for continuous variables was performed. Absolute and
relative frequencies for categorical variables were estimated.
Bivariate analysis was performed for each study variable,
using one-way and two-way analysis of variance (ANOVA)
for continuous variables and chi-squared for nominal or cate-
gorical ordinal variables. A comparative analysis of variable
frequencies, with a significance level of 0.05, was performed.
A logistic regression in four models, both block and for-
ward stepwise, was conducted, using as dependent variables:
(1) rheumatic disease plus UMSK; (2) rheumatic disease, ex-
cluding UMSK; (3) rheumatic inflammatory disease (RA, un-
differentiated arthritis, SLE, MCTD, inflammatory back pain,
SS, and SSc); and (4) noninflammatory rheumatic disease
(OA, mechanical back pain, fibromyalgia, and RRPS). The
WHO ICD-10 was used to create these categories [32].
Independent variables included those with clinical rele-
vance and/or s ta t i s t i ca l s ign i f icance (p ≤ 0.05) ,
sociodemographic variables, currently working, work involv-
ing loads, repetitive work, pain in the last 7 days, pain inten-
sity, some kind of treatment received, and functional disability
measured by HAQ-DI. This analysis aimed to identify those
variables associated with the presence of rheumatic disease,
which could be used as proxy predictors for derivation, from
primary to specialist care. The HAQ-DI score was categorized
according to values, with a cutoff of 0.8 [20].
Results
The Qom population in our study included a total of 2157
individuals living stably in the three districts of Rosario and
were all ≥18 years. Of these, 1759 (81.5 %) participated in the
epidemiological study, 103 in the pilot study, and 1656 in the
extended study. Three-hundred and twenty-two (14.9 %) in-
dividuals were considered absent and 76 (3.5 %) did not agree
to participate.
Of the total number of individuals included in the study
(n=1656), 1020 (61.5 %) were female, with mean age of
35.3 years (SD 13.9). Birthplace was reported as Chaco
Province by 1356 (81.8 %) individuals. A total of 1636
(98.7 %) participants spoke Spanish and 1028 (62.0 %) spoke
the Qom language.
The majority of surveyed individuals declared that they had
Qom ancestors, the mother being Qom in 93.1 % and the
father being Qom in 84.2 %. A total of 1381 (83.4 %) indi-
viduals reported some level of education, but only 338
(20.1 %) had completed primary school, 54 (3.2 %) secondary
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school, and 3 (0.1 %) the tertiary level. Only two individuals
(0.1 %) reported incomplete university studies. At the time of
the survey, 1060 (64.0 %) individuals were occupationally
active, but only 106 (10.1 %) had formal employment. With
respect to the type of work, 646 individuals (39.0 %) reported
work involving loads (≥4 kg) and 639 (38.5 %) reported their
work involved repetitive tasks. In relation to health coverage,
1444 (87.1 %) participants were users of the public health
system (Table 1).
Self-reported illnesses, in order of frequency, were gastritis
378 (21.5 %), arterial hypertension 318 (18.1 %), Chagas
disease 273 (15.5 %), venous insufficiency 218 (12.4 %),
heart disease 125 (7.1 %), obesity 119 (6.8 %), diabetes
mellitus 112 (6.4 %), and dyslipidemia 61 (3.5 %). A total
of 104 individuals (6.3 %) reported having a previous diagno-
sis of rheumatic disease, the most common being OA (20,
19.2 %) and RA (19, 18.2 %).
MSK pain was reported by 890 (53.7 %) participants. Of
471 (52.9 %) individuals who had been referred in the last
7 days, 376 (79.8 %) had no associated trauma. Pain at some
point in life (historical pain) was reported by 514 (57.7 %)
individuals. Both pain in the last 7 days and historical pain
were present in 278 (31.2 %) individuals.Within the subgroup
of individuals with pain during the last 7 days, 364 (77.3 %)
had severe pain (reported as Bquite a lot^ and Ba lot^).
Regarding pain adaptation (coping), 14 (3.0 %) reported not
being able to cope, 226 (48.0 %) partially able to cope, and
231 (49.0 %) adequate coping. A total of 81 (17.2 %) had
actual physical limitations in performing their daily tasks,
and 302 (64.1 %) individuals had an HAQ-DI≥0.8 (Table
2). The most common sites of MSK pain recorded in the last
7 days are shown in Fig. 1, with the most representative being
lumbar spine in 189 (19.3 %) participants, knees in 128
(13.0 %), and hands in 118 (12.0 %).
Of all individuals with MSK pain (n=890), 289 (32.4 %)
attended a primary care center to seek assistance, 6 (0.6 %)
turned to traditional medicine, 75 (8.4 %) received another
type of support, and 378 (42.4 %) reported not having sought
any assistance. A total of 142 (15.9 %) individuals did not
answer this question. A total 381 of 890 (42.8 %) positive
cases had received some kind of treatment; 281 (73.7 %) re-
ceived nonsteroidal anti-inflammatory drugs (NSAIDs), 16
(4.1 %) corticosteroids, and 10 (2.6 %) disease-modifying
anti-rheumatic drugs (DMARDs).
After evaluation by a rheumatologist, 752 (45.4 %) MSK
disorders and rheumatic diseases were diagnosed. The preva-
lence of rheumatic diseases, excluding UMSK, was 29.7 %.
The prevalence of inflammatory rheumatic diseases was 5.5%
and that of noninflammatory rheumatic diseases was 26.3 %.
The prevalence of each disease was as follows: mechanical
back pain (20.1 %), RRPS (2.9), OA (4.0 %), RA (2.4 %),
undifferentiated arthritis (0.3 %), inflammatory back pain
(0.2 %), SSc (0.1 %), primary SS (0.1 %), fibromyalgia
(0.1 %), MCTD (0.06 %), and SLE (0.06 %). A total of 260
(15.7 %) cases were classified as UMSK (Table 3).
A comparison between patients with diagnosed rheumatic
disease and UMSK versus healthy subjects (negative survey)
was performed. Variables with observed statistical significance
were age (37.3 vs 33.7 years, p<0.01), current work (68.0 vs
60.6 %, p<0.01), load work (43.8 vs 34.9 %, p<0.01), repet-
itive work (43.2 vs 34.7 %, p<0.01), presence of pain in the
last 7 days (62.3 vs 0.2 %, p<0.01), severe pain (62.6 vs
0.3 %, p<0.01), treatment received (50.3 vs 0.2 %, p<0.01),
and HAQ-DI≥0.8 (56.2 vs 8.6 %, p<0.01) (Table 4).
In comparing patients with diagnosed rheumatic diseases
(excluding UMSK) versus healthy subjects (negative survey),
variables with statistical significance were current work (67.9
Table 1 Sociodemographic characteristics of the Qom population
Sociodemographic variables N = 1656
n (%)
Female 1020 (61.5)
Age, mean (SD; range), years 35.3 (13.9; 18–105)
Marital statusa, (59)
With partner 1064 (64.2)
Without partner 481 (29.0)
Separated/divorced 52 (3.1)
Place of birth (province)
Chaco 1356 (81.8)
Santa Fe 266 (16.0)
Formosa 17 (1.0)
Buenos Aires 11 (0.6)









Primary school (completed) 338 (20.1)
Secondary school (completed) 54 (3.2)
Tertiary school (completed) 3 (0.1)
University studies (incomplete) 2 (0.1)
Current work 1060 (64.0)
Load work (≥4 kg) 646 (39.0)
Repetitive work 639 (38.5)




SD standard deviation, PAMI state social health coverage
aMissing data
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vs 60 %, p< 0.01), load work (44.2 vs 34.9 %, p< 0.01),
repetitive work (43.8 vs 34.7, p<0.01), pain in the last 7 days
(64.6 vs 0.2 %, p<0.01), treatment received (54.8 vs 0.2 %,
p< 0.01), severe pain (64.2 vs 0.3, p < 0.01), and HAQ-
DI≥0.8 (64.2 vs 8.6 %, p<0.01).
Comparing patients with inflammatory rheumatic diseases
versus healthy subjects (negative survey), variables with sta-
tistical significance were pain in the last 7 days (70.9 vs 0.2 %,
p<0.01), severe pain (70.9 vs 0.2 %, p<0.01), treatment re-
ceived (81.8 vs 0.2 %, p<0.01), and HAQ-DI≥0.8 (81.8 vs
8.6 %, p<0.01).
In the comparison between patients with noninflammatory
rheumatic diseases versus healthy subjects (negative survey),
variables with statistical significance were female sex (63.8 vs
57.2 %, p<0.01), current work (68.4 vs 60.6 %, p<0.01),
load work (45.7 vs 34.9 %, p<0.01), repetitive work (45.3
vs 34.7 %, p<0.01), pain in the last 7 days (63.9 vs 0.2 %,
p<0.01), severe pain (64.3 vs 0.3 %, p<0.01), treatment re-
ceived (51.6 vs 0.2 %, p<0.01), and HAQ-DI≥0.8 (49.2 vs
8.6 %, p<0.01).
Four models for multiple logistic regression analysis were
performed. The analysis aimed at identifying those variables
that could be used by the primary care physician as proxy for
referring patients to the specialist. The presence of pain in the
last 7 days and HAQ-DI≥0.8 were the variables significantly
more relevant in the four models, model 1, rheumatic disease
Table 2 Description of musculoskeletal pain in the last 7 days






Quite a lot 162 (34.4)
A lot 202 (42.9)
Adaptation to pain
Not being able to cope 14 (3.0)
Partially able to cope 226 (48.0)
Adequate coping 231 (49.0)
Physical limitation
Past physical limitation 71 (15.1)
Current physical limitation 81 (17.2)
Never had physical limitation 319 (67.7)
HAQ-DI score ≥ 0.8, n (%; 95 % IC) 302 (64.1; 59.6–68.4)
HAQ-DI Health Assessment Questionnaire Disability Index
Fig. 1 Sites of musculoskeletal
pain in the last 7 days
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plus UMSK: pain OR 549.2, 95 % confidence interval (CI)
134.0–2250.1, p<0.01 and HAQ-DI OR 7.26, 95 % CI 4.8–
10.9, p<0.01; model 2, rheumatic disease excluding UMSK:
pain OR 516.1, 95 % CI 123.6–2154.2, p<0.01 and HAQ-DI
OR 8.5, 95 % CI 5.3–13.8, p<0.01; model 3, inflammatory
rheumatic disease: pain OR 206.4, 95 % CI 21.9–1944.9,
p<0.01 and HAQ-DI OR 8.28, 95 % CI 1.1–61.0, p<0.03;
and finally, model 4, noninflammatory rheumatic disease:
pain OR 513.7, 95 % CI 122.9–2146.4, p<0.01 and HAQ-
DI OR 8.5, 95 % CI 5.2–13.8, p<0.01.
Discussion
The most relevant findings of this study were the high preva-
lence of RA, and a female to male ratio of 7:1, similar to the
one published by GLADAR [15]. On the basis of the overall
cases reported, 21 (52.5 %) were diagnosed during the present
study and 19 (47.5 %) had a prior diagnosis. In addition,
undifferentiated arthritis was diagnosed in six (0.3 %) individ-
uals; these participants were not taken into account in the
clinical follow-up data used in this paper.
The prevalence of RA, found here using COPCORD
methodology, was surpassed by that reported in 2011 for
the Yucatán Península of Mexico (2.8 %) [6]. Few studies
have been published on the RA prevalence among indig-
enous people using this type of methodology. In a recent
study in Guatemala [7], two regions were compared, one
urban and the other rural (where more than 60 % of in-
habitants belong to a native community, the Kaqchikel).
The prevalence of RA in the latter region was 0.8 versus
0.5 % in the urban area [7].
Table 3 Prevalence of
musculoskeletal disorders and





(%; 95 % CI)
n= 1656
Female n
(%; 95 % CI)
n = 1020
Male n
(%; 95 % CI)
n = 636
P valuea
Osteoarthritis 67 (4.0; 3.1–5.1) 41 (4.0; 2.8–5.4) 26 (4.0; 2.6–5.9) 0.5
Rheumatic regional pain
syndromes
48 (2.9; 2.1–3.8) 44 (4.3; 3.1–5.7) 4 (0.6;0.1–1.6) <0.01
Undifferentiated arthritis 5 (0.3; 0.09–0.7) 4 (0.3; 0.1–1.0) 1 (0.1; 0.003–0.8) 0.3
Mechanical back pain 333 (20.1; 18.2–22.1) 186 (18.2; 15.9–20.7) 147 (8.8; 7.5–10.3) 0.03
Inflammatory back pain 4 (0.2; 0.03–0.5) 0 4 (0.6; 0.1–1.6) –
Rheumatoid arthritis 40 (2.4; 1.7–3.2) 35 (3.4; 2.4–4.7) 5 (0.7; 0.2–1.8) <0.01
Systemic sclerosis
(scleroderma)
2 (0.1; 0.01–0.4) 1 (0.09; 0.002–0.5) 1 (0.1; 0.003–0.8) 0.6
Primary Sjögren syndrome 2 (0.1; 0.01–0.4) 1 (0.09; 0.002–0.5) 1 (0.1; 0.003–0.8) 0.6
Fibromyalgia 2 (0.1; 0.01–0.4) 1 (0.09; 0.002–0.5) 1 (0.1; 0.003–0.8) 0.6
Mixed connective tissue
disease
1 (0.06; 0.001–0.3) 1 (0.09; 0.002–0.5) 0 –
Systemic lupus
erythematosus
1 (0.06; 0.001–0.3) 1 (0.09; 0.002–0.5) 0 –
a Chi-squared test (dichotomous)
Table 4 Comparing individuals
with rheumatic disease and
unknown musculosketal
disorders and healthy subjects
(survey negative)
Variables Rheumatic disease
and UMKS n= 752
n (%)
Healthy subjects
(survey negative) n= 904
n (%)
P value
Female 443 (58.9) 577 (63.8) 0.04
Age, median (SD) 37.3 (14.1) 33.7 (13.5) <0.01
Current work 512 (68.0) 548 (60.6) <0.01
Load work ≥ 4 kg 330 (43.8) 316 (34.9) <0.01
Repetitive work 325 (43.2) 314 (34.7) <0.01
Pain in the last 7 days 469 (62.3) 2 (0.2) <0.01
Severe pain 471 (62.6) 3 (0.3) <0.01
Treatment received 379 (50.3) 2 (0.2) <0.01
Physical limitation 115 (15.2) 1 (0.1) 0.08
HAQ-DI ≥ 0.8 423 (56.2) 78 (8.6) <0.01
UMSK unknown MSK disorders, SD standard deviation, HAQ-DI Health Assessment Questionnaire Disability
Index
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Another study carried out using COPCORD methodology
in an indigenous community in Australia (Yarrabah popula-
tion) did not show any evidence of RA cases [33]. These
differences may be related to genetic and/or environmental
issues. It has been stated that indigenous Australians do not
present any evidence of RA [34], different to some native
communities of North America where the prevalence of RA
reaches 5–7 %; the most representative include the Chippewa
(6.8–7.1 %), Pima (5.3 %), Yakima (3.4 % in females), and
Tlingit (2.4 %) communities [35]. Furthermore, in these com-
munities, the presentation of RA is more aggressive and with
higher seropositivity.
A study in a native community of Canada (Manitoba’s
population) also reported a high prevalence of RA compared
with the overall white population in the same area. These data
were collected from a database of visit records at a reference
site (on-request visits), where it was observed that nearly twice
the number of records of medical attention belonged to pa-
tients who were part of the native community (40.9 vs 25.9 %,
p=0.000) [36].
In Argentina, two studies described the prevalence of RA
in the overall population. One study was conducted in
Tucumán (northwest region). The data used were obtained
from inpatient and outpatient records from public and private
health care facilities. A global RA prevalence rate of 1.97 per
1000 inhabitants (0.2 %) was reported. According to its au-
thors, 84 % of the inhabitants were European descendants,
whereas indigenous people represented only 10 % [37]. The
other study was conducted in Luján, Buenos Aires Province.
These data were collected from rheumatologists by a phone
survey. The prevalence of RAwas 0.9 % [38]; however, par-
ticipants’ ethnicities were not analyzed.
In our study, the finding involving family members with
RA was relevant. Six families were included; five had two
family members (mother and daughter) with a diagnosis of
RA, and the other family had three affected members (mother
and daughter with RA diagnosis and another daughter with
SLE diagnosis). This familial aggregation has not been found
in any previous COPCORD study. It has been observed that
the chance of developing RA, even of having positive sero-
logical results without developing disease, is very high among
first-degree family members in North American indigenous
populations [39, 40].
Another remarkable finding in the present study was the
high prevalence of MSK pain in general (positive cases) of
around 53.7 %, and particularly of pain during the last week
(52.9 %), related to significant functional disability measured
by HAQ-DI. In COPCORD surveys in native communities of
Guatemala [7] and Australia [32], the prevalence ofMSK pain
was of a lesser degree, around 4.5 and 33 %, respectively.
Another study carried out in a rural area of Iran showed a pain
prevalence of 41.9 % [41]. In relation to studies performed in
Latin America, Mexico showed an overall prevalence of
25.5 % [6], Cuba 43.9 % [8], Brazil 30.9 % [11], Venezuela
22.4 % [10], and Peru 46.6 % [9].
Mechanical back pain was the most prevalent identified
symptom in this study (20.1 %), mainly in women, compara-
ble to a COPCORD survey performed in rural Iran, with a
percentage of 23.4 % [41]. This similarity is probably owing
to the type of work performed by study participants, where
load work and repetitive tasks were common in both popula-
tions. In other COPCORD studies among indigenous people
in Guatemala [7] and Australia [33], the percentage of back
pain was of a lesser degree, 5 and 14 %, respectively. In ad-
ditional COPCORD studies in Latin America, Cuba showed
11.6 % [8], whereas this manifestation was not reported in
either Peru [9] or Brazil [11]. A study done in Mexico [41]
using COPCORDmethodology showed back pain prevalence
of 8 % and inflammatory back pain of 3 %. In the present
study, only 0.2 % of study participants demonstrated charac-
teristics of inflammatory back pain, all of them men.
In our study, the prevalence of RRPS was 2.9 % and sig-
nificantly more prevalent in women. RRPS was related to the
upper limbs, particularly rotator cuff tendinopathy, similar to
those published in other COPCORD studies [6–10, 42].
Mexican authors studied the prevalence of RRPS, using
COPCORD methodology, in different areas of the country.
The global prevalence reported was 5 % but with differences
related mainly to work activity [31].
In our study, the prevalence of detected OAwas 4 %, com-
parable with COPCORD studies performed in Brazil (4.1 %)
[11] and Guatemala (3.9 %) [7] but of lesser degree than the
results of studies in Mexico (10.2 %) [10] and Cuba (20.4 %)
[8]. The low prevalence of detected OA among the Qom com-
munity may be related to the low mean age of the study pop-
ulation (35.3 years, SD 13.9).
In relation to autoimmune diseases such as SLE and SSc,
the prevalence found in our study (0.06 and 0.1 %, respective-
ly) was similar to that found in other COPCORD studies [6,
8–11]. We also reported primary SS (0.1 %) and MCTD
(0.06 %) cases, which have not been described previously.
The low prevalence of fibromyalgia in our study (0.06 %)
is notable. This disease was not reported in studies in
Guatemala [7] or even in Australia [33]. The prevalence of
fibromyalgia in Mexico was 1.4 [6] and 2.5 % in Brazil [11].
We believe these differences may be owing to the perception
of indigenous people with respect to pain; in other words, they
may have greater pain tolerance.
In the present study, no cases of psoriasis, psoriatic arthritis,
or gout were found. Toloza et al. [43] reported that the first
two pathologies were infrequent among indigenous commu-
nities, especially in Central and South America. Comparing
differences between countries, the highest prevalence of pso-
riasis in Argentina, Chile, and Uruguay was observed where
the white population was higher. On the other hand, the prev-
alence of HLA-B27 is lower in Central and South America
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(<1 %) compared with North America (9–50 %) [39, 43].
More recently, Toloza et al. [44] published a study of an in-
digenous community in Puno, Bolivia, describing 16 cases of
psoriasis and psoriatic arthritis; six of these cases were
descended from native people (five from the Quechua com-
munity and one from the Aymara community). Those study
subjects belonging to indigenous communities denied any
cases among family members. Contrary to what was been
published previously, this was the first report on the presence
of psoriatic arthritis in native communities of South America.
In the Australian Yarrabah indigenous community, only four
cases of psoriatic arthritis have been detected [33]. Regarding
the absence of gout, similar to what was reported in
Guatemala [7] of only one identified case, this could be related
to the eating habits of native communities in Latin America.
On the contrary, among the Australian indigenous community
[33], the prevalence of this pathology was 9.7 % in males and
2.9 % in females [45]. According to the authors, this finding
was related to alcohol intake, the prevalence of overweight,
and metabolic syndrome.
As shown in the multivariable logistic regression analysis,
pain during the last 7 days and functional disability as mea-
sured by the HAQ-DI should prompt the primary care physi-
cian to refer these patients to a rheumatologist for a prompt
diagnosis and treatment.
The limitations of our study were as follows: a higher num-
ber of females were included, despite designing an intentional
search scheme for absent males. Participation by young sub-
jects (mean age 35.3) might be because they are the most
stable residents within the Qom community living in
Rosario. A known pattern of frequent migration exists be-
tween Rosario and the Qom home province of Chaco.
In conclusion, using COPCORD methodology, we found a
high prevalence of MSK disorders and rheumatic diseases in
an indigenous Qom community, especially mechanical back
pain and RA, the latter with a higher reported prevalence.
Future studies are needed to characterize RA among the
Qom people.
The use of COPCORD methodology to detect MSK disor-
ders and rheumatic diseases in an easy and rapid fashion must
be highlighted. It is important to note that clinical data provid-
ed by the patient on pain characteristics and functional disabil-
ity should be the most important aspect for general physicians
to take into account when MSK disorders and rheumatic dis-
eases are suspected, for quick referral to a specialist.
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